W
TECH icon

Wealthfront’s Bio-Techne TECH Stock Holding History

Wealthfront’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-544
Closed -$13K – 965
2015
Q3 		$13K Buy
544
+76
+16% +$1.91K ﹤0.01% 887
2015
Q2 		$12K Buy
468
+212
+83% +$5.29K ﹤0.01% 786
2015
Q1 		$6K Buy
256
+252
+6,300% +$5.99K ﹤0.01% 758
2014
Q4 		$0 Buy
+4
New +$92 ﹤0.01% 972

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Wealthfront's TECH Position: Q4 2015 in Review

Wealthfront sold out of Bio-Techne (TECH) in Q4 2015, closing a stake of 544 shares — an estimated $13K sold.

Wealthfront first reported a position in TECH in Q4 2014 and held it in 4 quarters. The position peaked at $13K in Q3 2015. 260 funds tracked by Wall St. Rank hold TECH as of Q4 2015.

  • Wealthfront reported no remaining Bio-Techne position as of Q4 2015 after selling out during the quarter.
  • Wealthfront sold 544 Bio-Techne shares in Q4 2015, an estimated $13K.
  • Wealthfront first reported a position in Bio-Techne in Q4 2014 and held it in 4 quarters.
  • Wealthfront's Bio-Techne position peaked at $13K in Q3 2015.
  • 260 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2015.

Based on Wealthfront's 13F filing for Q4 2015, filed 17 Feb 2016.